SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-24-000349
Filing Date
2024-03-28
Accepted
2024-03-28 16:07:59
Documents
12

Document Format Files

Seq Description Document Type Size
1 GILEAD SCIENCES, INC. - DEFA14A lgild2024_defa14a.htm DEFA14A 47220
2 GRAPHIC check01.jpg GRAPHIC 1441
3 GRAPHIC lgild2024_defa14ax1x2.jpg GRAPHIC 37217
4 GRAPHIC lgild2024_defa14ax1x3.jpg GRAPHIC 4953
5 GRAPHIC lgild2024_defa14ax1x4.jpg GRAPHIC 5060
6 GRAPHIC lgild2024_defa14ax1x5.jpg GRAPHIC 5704
7 GRAPHIC lgild2024_defa14ax1x6.jpg GRAPHIC 3355
8 GRAPHIC lgild2024_defa14ax2x1.jpg GRAPHIC 1130
9 GRAPHIC lgild2024_defa14ax2x2.jpg GRAPHIC 1114
10 GRAPHIC logo.jpg GRAPHIC 12727
11 GRAPHIC logo1.jpg GRAPHIC 8748
12 GRAPHIC uncheck.jpg GRAPHIC 1060
  Complete submission text file 0001308179-24-000349.txt   163625
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19731 | Film No.: 24798893
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)